Clinical trial
Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac…
NCT00467311 · National Heart Institute, Mexico, Other · Completed
Key facts
| NCT number | NCT00467311 |
|---|---|
| Title | Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients |
| Official title | Diagnostic, Transversal, Comparative, Not Randomized Trial for the Evaluation of Cystatin C as an Early Marker of Contrast-Medium Nephropathy in High-and-Intermedium-Risk Patients Undergoing to Cardiac Catheterization |
| Lead sponsor | National Heart Institute, Mexico, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Contrast Induced Nephropathy, Acute Renal Failure |
| Enrollment | 66 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Apr 30, 2007 |
| Last update posted | May 8, 2008 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: